Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-sequence, 3-periods, 3-treatments, Phase I Clinical Trial to Evaluate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between Tegoprazan and Aspirin in Healthy Male Adult Volunteers

NCT07853248 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

NCT NCT07853248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07853248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-sequence, 3-periods, 3-treatments, Phase I Clinical Trial to Evaluate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between Tegoprazan and Aspirin in Healthy Male Adult Volunteers
Lead sponsor
HK inno.N Corporation
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 14, 2026
Completion date
April 30, 2027
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult male